BioNxt Solutions (BioNxt Solutions) Cash-to-Debt : 0.02 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. BioNxt Solutions's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.02.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, BioNxt Solutions couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for BioNxt Solutions's Cash-to-Debt or its related term are showing as below:

BNXTF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02 Med: 0.41 Max: 3.03
Current: 0.02

During the past 6 years, BioNxt Solutions's highest Cash to Debt Ratio was 3.03. The lowest was 0.02. And the median was 0.41.

BNXTF's Cash-to-Debt is ranked worse than
95.32% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs BNXTF: 0.02

BioNxt Solutions Cash-to-Debt Historical Data

The historical data trend for BioNxt Solutions's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

BioNxt Solutions Cash-to-Debt Chart

BioNxt Solutions Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.21

0.78

0.25

0.03

0.07

BioNxt Solutions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															0.03	0.41	0.12	0.07	0.02

Competitive Comparison of BioNxt Solutions's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNxt Solutions's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's Cash-to-Debt falls into.

BioNxt Solutions Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

BioNxt Solutions's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.271	/	(3.648	+	0)
	=	0.07

BioNxt Solutions's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.061	/	(3.781	+	0)
	=	0.02

BioNxt Solutions (OTCPK:BNXTF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

BioNxt Solutions Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNxt Solutions (BioNxt Solutions) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (OTCPK:BNXTF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

BXT:Germany BNXT:Canada

Address

1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1

Website

https://www.bionxt.com

BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.